CIA
ALT icon

Concurrent Investment Advisors’s Altimmune ALT Stock Holding History

Concurrent Investment Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.1K Buy
28,649
+2,141
+8% +$6.39K ﹤0.01% 2035
2026
Q1 		$81.6K Hold
26,508
– – ﹤0.01% 1840
2025
Q4 		$95.7K Buy
26,508
+2,500
+10% +$10.9K ﹤0.01% 1709
2025
Q3 		$90.5K Sell
24,008
-1,250
-5% -$4.83K ﹤0.01% 1427
2025
Q2 		$97.7K Buy
25,258
+3,565
+16% +$19.3K ﹤0.01% 1331
2025
Q1 		$108K Buy
+21,693
New +$137K ﹤0.01% 1177

Other funds holding ALT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
BWM
Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Concurrent Investment Advisors's ALT Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Altimmune (ALT) stake by 8.1% in Q2 2026, buying an estimated $6.39K and bringing the position to 28,649 shares worth $87.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2035.

Concurrent Investment Advisors first reported a position in ALT in Q1 2025 and has held it in 6 quarters since. The position peaked at $108K in Q1 2025. 38 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Concurrent Investment Advisors held 28,649 shares of Altimmune worth $87.1K as of Q2 2026.
  • Concurrent Investment Advisors bought 2,141 Altimmune shares in Q2 2026, an estimated $6.39K.
  • Altimmune made up ﹤0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #2035 holding.
  • Concurrent Investment Advisors first reported a position in Altimmune in Q1 2025 and has held it in 6 quarters since.
  • Concurrent Investment Advisors's Altimmune position peaked at $108K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.